An Act prohibiting discriminatory practices against applicants and enrollees under certain insurance policies based on claims or prescriptions involving prophylaxis HIV medication.

HB 719 prohibits Pennsylvania insurance companies from denying coverage, limiting benefits, or charging higher rates to applicants or policyholders solely because they use FDA-approved HIV prevention medications (PrEP for pre-exposure or PEP for post-exposure prophylaxis). The bill directly affects individuals seeking or maintaining insurance coverage who are prescribed these medications for HIV prevention. It bans specific "adverse actions" like coverage denial, reduced benefits, or discriminatory pricing based solely on PrEP or PEP use. The law takes effect 60 days after enactment and enforces violations through existing insurance fraud and unfair practice laws.